Results
Johnson Pharmacare FY26 Loss ₹5573 Lakhs, Disclaimer Opinion
Johnson Pharmacare reported a standalone net loss of ₹5573.39 lakhs for FY26, with a disclaimer of opinion from auditors VRSK & Associates.
Auditors cited non-compliance with Ind AS, non-provision of
